MRD as a surrogate endpoint for AML therapy VJHemOnc – Video Journal of Hematology & HemOnc 1:58 4 months ago 115 Далее Скачать
The possibility of using MRD as a surrogate endpoint for PFS and OS in myeloma clinical trials VJHemOnc – Video Journal of Hematology & HemOnc 3:58 1 year ago 214 Далее Скачать
ASH 2019: Novel Therapies and a Trial Using MRD as a Surrogate Endpoint | Dr. Nina Shah HealthTree Foundation for Multiple Myeloma 2:06 5 years ago 191 Далее Скачать
Using MRD as an endpoint in clinical trials VJHemOnc – Video Journal of Hematology & HemOnc 1:38 5 years ago 50 Далее Скачать
The role of MRD in AML regulatory decision making VJHemOnc – Video Journal of Hematology & HemOnc 3:27 3 years ago 192 Далее Скачать
How can MRD guide treatment of AML? VJHemOnc – Video Journal of Hematology & HemOnc 1:39 2 years ago 236 Далее Скачать
The current role of MRD in AML and challenges with implementing this in clinical practice VJHemOnc – Video Journal of Hematology & HemOnc 1:26 1 year ago 151 Далее Скачать
Influence of AML differentiation state on outcomes of patients treated with frontline HMA + ven VJHemOnc – Video Journal of Hematology & HemOnc 2:39 2 days ago 60 Далее Скачать
Surrogate Endpoints for New Drug Discovery in Acute Lymphoblastic Leukemia OncLive 3:58 10 years ago 164 Далее Скачать
Minimal Residual Disease as a Surrogate Endpoint in Hematologic Cancer Trials: Session 4 Duke Margolis 1:04:42 8 years ago 396 Далее Скачать
Minimal Residual Disease as a Surrogate Endpoint in Hematologic Cancer Trials: Session 1 Duke Margolis 1:01:18 8 years ago 326 Далее Скачать
Standardizing MRD techniques after FDA approval as a surrogate endpoint in myeloma trials VJHemOnc – Video Journal of Hematology & HemOnc 1:18 2 months ago 19 Далее Скачать
The importance of MRD in multiple myeloma in guiding treatment decisions & access to therapies VJHemOnc – Video Journal of Hematology & HemOnc 3:10 1 year ago 352 Далее Скачать
Should minimal residual disease (MRD) testing be routinely performed? International Myeloma Foundation 5:05 5 years ago 524 Далее Скачать
Minimal Residual Disease as a Surrogate Endpoint in Hematologic Cancer Trials: Opening Remarks Duke Margolis 1:29:25 8 years ago 449 Далее Скачать
Acute leukemias: is MRD already a surrogate for survival? VJHemOnc – Video Journal of Hematology & HemOnc 12:59 6 years ago 436 Далее Скачать
MRD detection techniques in AML: pros and cons VJHemOnc – Video Journal of Hematology & HemOnc 1:45 6 years ago 237 Далее Скачать
